Ioannis Zerdes

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Early Breast Cancer

Estrogen Receptor

Top Venues

Nature communications

Molecular oncology

NPJ breast cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Kang Wang, Ioannis Zerdes, Henrik J Johansson, Dhifaf Sarhan, Yizhe Sun, Dimitris C Kanellis, Emmanouil G Sifakis, Artur Mezheyeuski, Xingrong Liu, Niklas Loman, Ingrid Hedenfalk, Jonas Bergh, Jiri Bartek, Thomas Hatschek, Janne Lehtiö, Alexios Matikas, Theodoros Foukakis
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer. Nature communications 15 (1) (2024)
Kang Wang, Ioannis Zerdes, Henrik J Johansson, Dhifaf Sarhan, Yizhe Sun, Dimitris C Kanellis, Emmanouil G Sifakis, Artur Mezheyeuski, Xingrong Liu, Niklas Loman, Ingrid Hedenfalk, Jonas Bergh, Jiri Bartek, Thomas Hatschek, Janne Lehtiö, Alexios Matikas, Theodoros Foukakis
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer. Nature communications 15 (1) (2024)
Kang Wang, Ioannis Zerdes, Henrik J Johansson, Dhifaf Sarhan, Yizhe Sun, Dimitris C Kanellis, Emmanouil G Sifakis, Artur Mezheyeuski, Xingrong Liu, Niklas Loman, Ingrid Hedenfalk, Jonas Bergh, Jiri Bartek, Thomas Hatschek, Janne Lehtiö, Alexios Matikas, Theodoros Foukakis
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer. Nature communications 15 (1) (2024)
Ioannis Zerdes, Alexios Matikas, Theodoros Foukakis
The interplay between eosinophils and T cells in breast cancer immunotherapy. Molecular oncology (2023)
Ioannis Zerdes, Alexios Matikas, Theodoros Foukakis
The interplay between eosinophils and T-cells in breast cancer immunotherapy. Molecular oncology (2023)
Justus Rosin, Ella Svegrup, Antonios Valachis, Ioannis Zerdes
Discordance of PIK3CA mutational status between primary and metastatic breast cancer: a systematic review and meta-analysis. Breast cancer research and treatment (2023)
Alexios Matikas, Hemming Johansson, Per Grybäck, Judith Bjöhle, Balazs Acs, Ceren Boyaci, Tobias Lekberg, Hanna Fredholm, Ellinor Elinder, Sara Margolin, Erika Isaksson-Friman, Ana Bosch, Henrik Lindman, Jamila Arda, Anne Andersson, Susanne Agartz, Mats Hellström, Ioannis Zerdes, Johan Hartman, Jonas Bergh, Thomas Hatschek, Theodoros Foukakis
Survival outcomes, digital TILs and on-treatment PET/CT during neoadjuvant therapy for HER2-positive breast cancer: results from the randomized PREDIX HER2 trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Ioannis Zerdes, Michele Simonetti, Alexios Matikas, Luuk Harbers, Balazs Acs, Ceren Boyaci, Ning Zhang, Dimitrios Salgkamis, Susanne Agartz, Pablo Moreno-Ruiz, Yalai Bai, David L Rimm, Johan Hartman, Artur Mezheyeuski, Jonas Bergh, Nicola Crosetto, Theodoros Foukakis
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study. NPJ breast cancer 7 (1) (2021)
Ioannis Zerdes, Emmanouil G Sifakis, Alexios Matikas, Sebastian Chrétien, Nicholas P Tobin, Johan Hartman, George Z Rassidakis, Jonas Bergh, Theodoros Foukakis
Programmed death-ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21-gene and 70-gene signatures in estrogen receptor-positive disease. Molecular oncology 14 (5) (2020)